Trial Profile
A Phase II Study to Assess the Efficacy and Safety of a Single Inhaled Dose of Albuterol Sulfate Dry Powder Via the Trivair Deposition System Versus Albuterol Sulfate HFA pMDI in Patients With Intermittent or Persistent Mild Asthma.
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Salbutamol (Primary) ; Salbutamol sulfate
- Indications Asthma
- Focus Therapeutic Use
- Sponsors Acerus Pharmaceuticals
- 09 Mar 2018 Planned End Date changed from 1 Jun 2011 to 1 Oct 2015.
- 09 Mar 2018 Planned primary completion date changed from 1 Jun 2011 to 1 Apr 2013.
- 09 Mar 2018 Planned initiation date changed from 1 Mar 2011 to 1 Nov 2012.